# Experimental glass ionomer cement modified by the incorporation of nanoselenuim: antibacterial activity, cytocompatibility and compressive strength

**Authors:** Mariam Romany Wadee, Yasser F. Gomaa, Reem Gamal

PMC · DOI: 10.1186/s12903-025-07504-y · 2025-12-27

## TL;DR

This study shows that adding nanoselenium to dental cement improves its antibacterial properties without harming its strength or cell compatibility.

## Contribution

The novel contribution is demonstrating that nanoselenium enhances GIC's antibacterial activity while maintaining compressive strength and improving cytocompatibility.

## Key findings

- NSe at 150 ppm provided extended antibacterial activity against S. mutans for 7 days.
- Low NSe concentrations (75 ppm) increased oral epithelial cell viability.
- Compressive strength remained unaffected across all NSe concentrations tested.

## Abstract

The use of restorations with antibacterial activity has become mandatory to control secondary caries, especially in atraumatic restorative treatment (ART). Therefore, this study was conducted to enhance the antibacterial activity of conventional glass ionomer cement (GIC) by adding nanoselenium (NSe) and to assess the impact on its cytocompatibility and compressive strength.

NSe was prepared and characterized, and its minimum inhibitory concentration (MIC) against Streptococcus mutans (S. mutans) was determined via the broth microdilution technique. Based on the MIC, grouping was performed. Group I included unmodified GIC samples mixed with water, and groups II–IV included GIC samples mixed with three different concentrations (75, 112.5, and 150 ppm, respectively) of the NSe suspension. Antibacterial activity against S. mutans was assessed via an agar disc diffusion test over four time intervals (24, 48, 72 h, and 7 days). The cytocompatibility of 100% and 10% concentrations of the sample extract was evaluated via a sulforhodamine B (SRB) assay against oral epithelial cells. Additionally, compressive strength testing was performed according to ISO 9917-1 using a universal testing machine.

Regarding antibacterial activity, group IV presented significantly higher values than the other groups, followed by group III, at all time intervals. For cytocompatibility, group II had higher values of cell viability at both concentrations. For all groups, the 10% concentration had significantly higher values of cell viability than the 100% concentration. Moreover, none of the groups showed a statistically significant difference in compressive strength.

The addition of NSe at concentrations up to 150 ppm resulted in extended antibacterial activity against S. mutans for up to 7 days without affecting its compressive strength. Furthermore, the addition of NSe at a low concentration, such as 75 ppm, increased the viability of oral epithelial cells.

## Linked entities

- **Chemicals:** NSe (PubChem CID 11998180)
- **Species:** Streptococcus mutans (taxon 1309)

## Full-text entities

- **Genes:** Eno2 (enolase 2, gamma neuronal) [NCBI Gene 13807] {aka D6Ertd375e, Eno-2, NSE}
- **Diseases:** ischemia (MESH:D007511), hypoxia (MESH:D000860), viral (MESH:D014777), systemic diseases (MESH:D034721), Se deficiency (MESH:D007153), fracture (MESH:D050723), inflammatory (MESH:D007249), oral disease (MESH:D009059), bacterial infections (MESH:D001424), Dental caries (MESH:D003731), cytotoxic (MESH:D064420), GIC (MESH:C567350)
- **Chemicals:** ATP (MESH:D000255), acetic acid (MESH:D019342), ROS (MESH:D017382), copper (MESH:D003300), carbohydrates (MESH:D002241), methylselenocysteine (MESH:C002979), free radicals (MESH:D005609), streptomycin (MESH:D013307), selenocystine (MESH:C009226), carbon (MESH:D002244), penicillin (MESH:D010406), polyacrylic acid (MESH:C006903), H2O2 (MESH:D006861), water (MESH:D014867), lipopolysaccharide (MESH:D008070), polysaccharide (MESH:D011134), aluminum (MESH:D000535), SRB (MESH:C022027), Se (MESH:D012643), CO2 (MESH:D002245), MTT (MESH:C070243), mineral trioxide aggregate (MESH:C086631), agar (MESH:D000362), Na2SeO3 (MESH:D018038), calcium selenite (MESH:C075632), Chitosan (MESH:D048271), fluoride (MESH:D005459), amoxicillin (MESH:D000658), calcium (MESH:D002118), trichloroacetic acid (MESH:D014238), Lipid (MESH:D008055), selenomethionine (MESH:D012645), P (MESH:D010758), ascorbic acid (MESH:D001205), Tris (hydroxymethyl) aminomethane (MESH:D014325), 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2 H-tetrazolium bromide (-)
- **Species:** Saccharomyces cerevisiae (baker's yeast, species) [taxon 4932], Escherichia coli (E. coli, species) [taxon 562], Streptococcus mutans ATCC 25175 (strain) [taxon 1257041], Homo sapiens (human, species) [taxon 9606], Candida albicans (species) [taxon 5476], Streptococcus mutans (species) [taxon 1309], Staphylococcus aureus (species) [taxon 1280], Enterococcus faecalis (species) [taxon 1351]
- **Cell lines:** 1683 — Homo sapiens (Human), Finite cell line (CVCL_0Q03), MC3T3-E1 — Mus musculus (Mouse), Spontaneously immortalized cell line (CVCL_0409), ABC-TC4365 — Homo sapiens (Human), Lung adenocarcinoma, Cancer cell line (CVCL_UW51), ATCC 25175 — Homo sapiens (Human), Lung adenocarcinoma, Cancer cell line (CVCL_0023)

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12853819/full.md

---
Source: https://tomesphere.com/paper/PMC12853819